Infectious Risks and Optimal Strength of Maintenance Immunosuppressants in Rituximab-Treated Kidney Transplantation

BACKGROUND: Rituximab, an anti-CD20 antibody, effectively depletes B lymphocytes. It is not clear whether the use of conventional doses of mycophenolate mofetil (MMF), methylprednisolone and tacrolimus as maintenance immunosuppression in rituximab-treated kidney transplantation is associated with in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Baek, Chung Hee, Yang, Won Seok, Park, Kyung Sun, Han, Duck Jong, Park, Jae Berm, Park, Su-Kil
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2012
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350352/
https://ncbi.nlm.nih.gov/pubmed/22619669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000337339
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak